Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia

A. Argiris, G. S A Longo, R. Gorlick, W. Tong, P. Steinherz, J. R. Bertino

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Acute myelocytic leukemia (AML) is a malignancy that is intrinsically resistant to methotrexate (MTX). AML blasts, when incubated with radiolabeled MTX, form lower amounts of long chain polyglutamates compared to acute lymphocytic leukemia (ALL) blasts, thus providing an explanation for their lack of responsiveness to MTX. Leukemic blasts obtained from two children with acute megakaryocytic leukemia (M7 subtype) when incubated with radiolabeled MTX showed increased accumulation of total as well as long chain MTX polyglutamates, comparable to levels previously demonstrated in another subtype of AML, acute monocytic leukemia (M5), as well as in blasts from patients with pre-B ALL. We suggest that M7-AML patients with blasts showing increased MIX polyglutamylation might benefit from treatment with MTX.

Original languageEnglish (US)
Pages (from-to)886-889
Number of pages4
JournalLeukemia
Volume11
Issue number6
StatePublished - 1997
Externally publishedYes

Fingerprint

Leukemia, Megakaryoblastic, Acute
Acute Myeloid Leukemia
Methotrexate
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Leukemia, Monocytic, Acute
B-Cell Leukemia
Polyglutamic Acid
Neoplasms

Keywords

  • Acute megakaryocytic leukemia
  • Acute myelocytic leukemia
  • Methotrexate
  • Polyglutamylation

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Argiris, A., Longo, G. S. A., Gorlick, R., Tong, W., Steinherz, P., & Bertino, J. R. (1997). Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia. Leukemia, 11(6), 886-889.

Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia. / Argiris, A.; Longo, G. S A; Gorlick, R.; Tong, W.; Steinherz, P.; Bertino, J. R.

In: Leukemia, Vol. 11, No. 6, 1997, p. 886-889.

Research output: Contribution to journalArticle

Argiris, A, Longo, GSA, Gorlick, R, Tong, W, Steinherz, P & Bertino, JR 1997, 'Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia', Leukemia, vol. 11, no. 6, pp. 886-889.
Argiris, A. ; Longo, G. S A ; Gorlick, R. ; Tong, W. ; Steinherz, P. ; Bertino, J. R. / Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia. In: Leukemia. 1997 ; Vol. 11, No. 6. pp. 886-889.
@article{edda7d84cd0946fb828a36b15ca5202b,
title = "Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia",
abstract = "Acute myelocytic leukemia (AML) is a malignancy that is intrinsically resistant to methotrexate (MTX). AML blasts, when incubated with radiolabeled MTX, form lower amounts of long chain polyglutamates compared to acute lymphocytic leukemia (ALL) blasts, thus providing an explanation for their lack of responsiveness to MTX. Leukemic blasts obtained from two children with acute megakaryocytic leukemia (M7 subtype) when incubated with radiolabeled MTX showed increased accumulation of total as well as long chain MTX polyglutamates, comparable to levels previously demonstrated in another subtype of AML, acute monocytic leukemia (M5), as well as in blasts from patients with pre-B ALL. We suggest that M7-AML patients with blasts showing increased MIX polyglutamylation might benefit from treatment with MTX.",
keywords = "Acute megakaryocytic leukemia, Acute myelocytic leukemia, Methotrexate, Polyglutamylation",
author = "A. Argiris and Longo, {G. S A} and R. Gorlick and W. Tong and P. Steinherz and Bertino, {J. R.}",
year = "1997",
language = "English (US)",
volume = "11",
pages = "886--889",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Increased methotrexate polyglutamylation in acute megakaryocytic leukemia (M7) compared to other subtypes of acute myelocytic leukemia

AU - Argiris, A.

AU - Longo, G. S A

AU - Gorlick, R.

AU - Tong, W.

AU - Steinherz, P.

AU - Bertino, J. R.

PY - 1997

Y1 - 1997

N2 - Acute myelocytic leukemia (AML) is a malignancy that is intrinsically resistant to methotrexate (MTX). AML blasts, when incubated with radiolabeled MTX, form lower amounts of long chain polyglutamates compared to acute lymphocytic leukemia (ALL) blasts, thus providing an explanation for their lack of responsiveness to MTX. Leukemic blasts obtained from two children with acute megakaryocytic leukemia (M7 subtype) when incubated with radiolabeled MTX showed increased accumulation of total as well as long chain MTX polyglutamates, comparable to levels previously demonstrated in another subtype of AML, acute monocytic leukemia (M5), as well as in blasts from patients with pre-B ALL. We suggest that M7-AML patients with blasts showing increased MIX polyglutamylation might benefit from treatment with MTX.

AB - Acute myelocytic leukemia (AML) is a malignancy that is intrinsically resistant to methotrexate (MTX). AML blasts, when incubated with radiolabeled MTX, form lower amounts of long chain polyglutamates compared to acute lymphocytic leukemia (ALL) blasts, thus providing an explanation for their lack of responsiveness to MTX. Leukemic blasts obtained from two children with acute megakaryocytic leukemia (M7 subtype) when incubated with radiolabeled MTX showed increased accumulation of total as well as long chain MTX polyglutamates, comparable to levels previously demonstrated in another subtype of AML, acute monocytic leukemia (M5), as well as in blasts from patients with pre-B ALL. We suggest that M7-AML patients with blasts showing increased MIX polyglutamylation might benefit from treatment with MTX.

KW - Acute megakaryocytic leukemia

KW - Acute myelocytic leukemia

KW - Methotrexate

KW - Polyglutamylation

UR - http://www.scopus.com/inward/record.url?scp=0030927589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030927589&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 886

EP - 889

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 6

ER -